Enzo Biochem, Inc.

Enzo Biochem Inc (Enzo Biochem) is a life sciences and biotechnology company with a focus on harnessing genetic processes for the development of research tools, therapeutics and diagnostics. It also provides reference laboratory services to the medical community. The company focuses on the development of enabling technologies in the fields of gene regulation and modification. Enzo Biochem’s technologies find application in the pharmaceutical and biomedical research markets. The company’s gene analysis has led to the development of several major therapeutic candidates for the treatment of viral and immunological based disorders. The company operates in the US, Switzerland, Benelux, Germany, France, and the UK. Enzo Biochem is headquartered in New York, the US.The company reported revenues of (US Dollars) US$104.7 million for the fiscal year ended July 2018 (FY2018), a decrease of 2.9% over FY2017. The operating loss of the company was US$12.2 million in FY2018, compared to an operating loss of US$3.1 million in FY2017. The net loss of the company was US$10.3 million in FY2018, compared to a net loss of US$2.5 million in FY2017. Company United States 527 Madison Ave jjohnson@enzo.com http://www.enzo.com